Effects of metformin treatment on serum levels of C-reactive protein and interleukin-6 in women with polycystic ovary syndrome: a meta-analysis

@inproceedings{Wang2017EffectsOM,
  title={Effects of metformin treatment on serum levels of C-reactive protein and interleukin-6 in women with polycystic ovary syndrome: a meta-analysis},
  author={Jiao Wang and Lingyan Zhu and Kaixiang Hu and Yunliang Tang and Xiangxia Zeng and Jianying Liu and Jixiong Xu},
  booktitle={Medicine},
  year={2017}
}
BACKGROUND Metformin is effective for the treatment of polycystic ovary syndrome (PCOS), but conflicting results regarding its impact on serum levels of C-reactive protein (CRP) and interleukin-6 (IL-6) in women with PCOS have been reported. To provide high-quality evidence about the effect of treatment with metformin on CRP and IL-6 in PCOS, relevant studies that assessed the serum levels of CRP and IL-6 in women with PCOS receiving metformin treatment were reviewed and analyzed. METHODS A… CONTINUE READING

References

Publications referenced by this paper.
Showing 1-10 of 47 references

Comparison of two doses of metformin ( 2 . 5 and 1 5 g / day ) for the treatment of polycystic ovary 12

  • RV Bruno, MA deAvila, FB Neves
  • Fertil Steril
  • 2016

Similar Papers

Loading similar papers…